Description
JH-II-127 is a selective inhibitor of leucine-rich repeat kinase 2 (LRRK2), a potential therapeutic target for neurodegenerative disease. It inhibits phosphorylation of Ser910 and Ser935 in both wild-type LRRK2 and the G2019S mutant.
| Product Unit Size | Cost | Quantity | Stock |
|---|
JH-II-127 is a selective inhibitor of leucine-rich repeat kinase 2 (LRRK2), a potential therapeutic target for neurodegenerative disease. It inhibits phosphorylation of Ser910 and Ser935 in both wild-type LRRK2 and the G2019S mutant.
| Cas No. | 1700693-08-8 |
|---|---|
| Purity | ≥98% |
| Formula | C19H21ClN6O3 |
| Formula Wt. | 416.87 |
| IUPAC Name | (4-{[5-Chloro-4-(methylamino)-3H-pyrrolo[2,3-d]pyrimidin-2-yl]amino}-3-methoxyphenyl)(4-morpholinyl)methanone |
| Synonym | Pyrrolopyrimidine |
| Solubility | DMSO |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet |
Hatcher J., Zhang J., et al. Discovery of a Pyrrolopyrimidine (JH-II-127), a Highly Potent, Selective, and Brain Penetrant LRRK2 Inhibitor. ACS Med Chem Lett. 6(5):584-9 (2015). PMID: 26005538.
Neuroactive mycotoxin produced by Penicillum an...
Vitamin D, calcitriol prodrug; VDR agonist.
Imidazole; 14-α demethylase inhibitor, potenti...
NSAID; COX-1/2 and PDE inhibitor.
pan-PI3K inhibitor.
Fermentation impurity
Synthetic progestogen; contraceptive.
K+-sparing diuretic; ENaC and acid-sensing ion ...
Endogenous peptide, involved in paracrine and a...
Type A trichothecene mycotoxin produced by Fusa...
Histamine H1 antagonist, FIASMA.
Antioxidant.
Cathelicidin derivative, antimicrobial peptide,...
Synthetic somatostatin analog, peptide; somatos...
Cyclohexanecarboxylic acid found in various pla...
Aspartyl protease inhibitor.
PKA inhibitor, potential ROCK, S6K1, MSK1, PKB ...
Triazole; 14-α demethylase inhibitor, potentia...
ATP-sensitive K+ channel activator, α-adrenerg...
Dual inhibitor of p70S6K and Akt.